A review and analysis of seven tirzepatide trials covering up to 72 weeks of treatment found that tirzepatide produced significant, dose-dependent weight loss, with the clearest results emerging as people moved into higher doses
Early symptoms are often subtle and may be mistaken for other conditions, delaying diagnosis and treatment
What Happens After FDA Approval Even after FDA approval, there are several steps before retatrutide becomes widely available: Prescriptions and Availability Lilly will need to scale manufacturing, which typically begins well before approval Initial supply may be limited, similar to the early availability challenges seen with Mounjaro and Zepbound Prescriptions will initially require an in-person or telehealth consultation with a licensed provider Insurance Coverage Insurance coverage is not automatic upon FDA approval Private insurers will set their own coverage policies, which can take months to finalize Medicare and Medicaid coverage depends on the approved indication and ongoing policy decisions The Medicare Inflation Reduction Act drug price negotiation program may eventually apply Pricing Context Current GLP-1 drug pricing provides context for what retatrutide might cost, though Lilly has not announced pricing: GoodRx has offered introductory pricing of $199/month for certain GLP-1 medications
2025 Feb 10;12(5):uhaf043
Unscented means theyve used a chemical to mask a scent, and those chemicals can be irritating, Dr
